Skip to main content

C-RAD order intake in Q1 sums up to 14,7 MSEK

Press release 2014-04-16

C-RAD AB with its three fully owned subsidiaries and three international sales companies are all active in the field of radiation therapy. At Annual General Meeting C-RAD is presenting the order intake for the first quarter in the fiscal year 2014.


The order intake in Q1/2014 sums up to 14,7 MSEK. With 9,1 MSEK the order intake for the products Sentinel, Catalyst and the Cyrpa Laser increased with more than 200 % compared to the same period in 2013.


Tim Thurn, CEO, C-RAD AB:

“I am very satisfied with the performance in the first quarter. Outstanding results can be reported from the German market.”

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666947, E-mail


The above information is price sensitive and must therefore be disclosed under the Securities Market Act (2077:528).


About C-RAD

C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 28 people. The activities in C-RAD AB originate from research and development at the Karolinska Institutet in Solna. Sales of the company’s first product, the C-RAD SentinelTM, started in 2007. Cooperation agreements have been signed with the Swedish company Elekta, the US company Varian  and the Belgian company IBA. C-RAD is represented by distributors specialized in radiation therapy on major markets. C-RAD has founded three companies for direct sales, C-RAD Incorporated in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. C-RAD has invested in 29 % of the laser company Cyrpa and with an option to acquire the remaining 71 %. C-RAD AB is since March 2010 listed at Nasdaq Omx First North Premier. Erik Penser Bankaktiebolag is appointed as C-RAD’s Certified Adviser.

For more information on C-RAD, please visit

Close Menu